Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.
Press releases published on October 21, 2025
Katalon Officially Launches Katalon Scout: The AI Quality Companion for the Vibe Coding Era
ATLANTA, GA, UNITED STATES, October 21, 2025 /EINPresswire.com/ -- Katalon, the global leader in AI-augmented software testing, today announced the official launch of Katalon Scout, an AI Quality Companion designed for the vibe coding era. Built on …
SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology
– Long-term continuous OGSIVEO treatment for up to 4 years was associated with further tumor size reductions, increase in objective response rate, sustained improvement in desmoid tumor symptoms and consistent safety profile – STAMFORD, Conn., Oct. 21, …
SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology
STAMFORD, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that long-term efficacy and safety data from the Phase 3 DeFi trial of OGSIVEO® (nirogacestat), an …
Caledonia Mining Corporation Plc Third Quarter Production at Blanket Mine
ST HELIER, Jersey, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc (NYSE AMERICAN, AIM and VFEX: CMCL) ("Caledonia" or "the Company") announces gold production from the Blanket Mine in Zimbabwe ("Blanket") for the quarter ended September …
PIVOT-PO Phase 3 Data Show Tebipenem HBr’s Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)
Data presented at IDWeek 2025 after study stopped early for efficacy Primary endpoint met, demonstrating non-inferiority of oral tebipenem HBr compared to intravenous treatment1 Data will be shared with regulatory authorities to support regulatory filings …
Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
WATERTOWN, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …
BGIN BLOCKCHAIN LIMITED Announces Pricing of Initial Public Offering
SINGAPORE, Oct. 20, 2025 (GLOBE NEWSWIRE) -- BGIN BLOCKCHAIN LIMITED (“BGIN” or “the Company”) (Nasdaq: BGIN), a digital asset technology company with proprietary cryptocurrency-mining technologies, today announced the pricing of its initial public …
The 6th Annual Seedly Personal Finance Festival Rallies Over 3,800 Singaporeans to Offer Insights into Economic Volatility
MoneyHero strengthens brand leadership and monetisation with 3,800-attendee Seedly Personal Finance Festival in Singapore Strong attendance signals strong demand for financial guidance amid economic uncertainty The Seedly x SingSaver Personal Finance …
BrightSpring Announces Pricing of Secondary Offering of Common Stock and Concurrent Share Repurchase
LOUISVILLE, Ky., Oct. 20, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex populations, today announced the pricing of …
XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
CALGARY, Alberta, Oct. 20, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and …